Skip to main content

Table 1 Types of post-transplantation malignancy from 2010 to 2014 in South Korea

From: Cancer risk after renal transplantation in South Korea: a nationwide population-based study

All cancer

Total (%)

Male, N (%)

Female, N (%)

104 (100)

63 (100)

41 (100)

Thyroid (C73)

24 (23.1)

12 (19.0)

12 (29.3)

Kidney (C64)

9 (8.7)

7 (11.1)

2 (4.9)

Stomach (C16)

7 (6.7)

7 (11.1)

 

Liver (C22)

6 (5.8)

5 (7.9)

1 (2.4)

Lung (C34)

6 (5.8)

5 (7.9)

1 (2.4)

Breast (C50)

6 (5.8)

 

6 (14.6)

Leukemia (C91, C92)

4 (3.8)

2 (3.1)

2 (4.9)

Skin (C44)

4 (3.8)

3 (4.8)

1 (2.4)

Myeloma (C90)

4 (3.8)

3 (4.8)

1 (2.4)

Non-Hodgkin lymphoma (C83, C85)

4 (3.8)

3 (4.8)

1 (2.4)

Kaposi sarcoma (C46)

3 (2.9)

3 (4.8)

 

Cervix uteri (C53)

3 (2.9)

 

3 (7.3)

Prostate (C61)

3 (2.9)

3 (4.8)

 

Brain (C71)

3 (2.9)

1 (1.6)

2 (4.9)

Pancreas (C25)

2 (1.9)

2 (3.1)

 

Bladder (C67)

2 (1.9)

1 (1.6)

1 (2.4)

Rectum (C19, C20)

2 (1.9)

1 (1.6)

1 (2.4)

Parotid gland (C07)

1 (0.1)

1 (1.6)

 

Colon (C18)

1 (0.1)

 

1 (2.4)

Anus (C21)

1 (0.1)

 

1 (2.4)

Larynx (C32)

1 (0.1)

1 (1.6)

 

Corpus uteri (C54)

1 (0.1)

 

1 (2.4)

Ovary (C56)

1 (0.1)

 

1 (2.4)

Renal pelvis (C65)

1 (0.1)

 

1 (2.4)

Ureter (C66)

1 (0.1)

 

1 (2.4)

Other site

4 (3.8)

3 (4.8)

1 (2.4)